• Latest Posts
Interview 10 Aug 2022

How the UK precision breeding bill could unshackle gene editing

Interview 21 Jul 2022

Finding investment opportunities in a bleak biotech stock market

Interview 12 Jul 2022

Where AI can’t go: PhoreMost’s quest to unearth protein degradation targets

Interview 10 Jan 2022

Leveraging Physics and Quantum Computing to Accelerate Drug Discovery

Interview 13 Oct 2021

Thinking About Risk Early on Is Key for Cell Therapy Success

Interview 23 Aug 2021

Behind the Scenes at Novo Seeds: Building Startups from the Ground up

ADVERTISEMENT
Interview 31 May 2021

What’s Ahead for European Biotech Startups After Covid?

Interview 26 May 2021

Immuno-Oncology: From Science Fiction to the Mainstream

Interview 19 May 2021

Are Biotech Startups Ready for Augmented Reality?

Interview 10 May 2021

The Rollercoaster of Repurposing an Arthritis Drug for Covid-19

Interview 21 Apr 2021

Changing Attitudes on Vaccine and Public Health Investment

Interview 5 Apr 2021

Base Editing: The Next Frontier in Genome Editing Technology 

ADVERTISEMENT